Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health In Tech (HIT) Shares Outstanding (Diluted Average) (2023 - 2025)

Health In Tech has reported Shares Outstanding (Diluted Average) over the past 3 years, most recently at $57.0 million for Q1 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $57.0 million for Q1 2025, up 10.1% from a year ago — trailing twelve months through Mar 2025 was $57.0 million (up 10.1% YoY), and the annual figure for FY2024 was $53.7 million, up 1264.84%.
  • Shares Outstanding (Diluted Average) for Q1 2025 was $57.0 million at Health In Tech, up from $53.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for HIT hit a ceiling of $57.0 million in Q1 2025 and a floor of $3.9 million in Q4 2023.
  • Median Shares Outstanding (Diluted Average) over the past 3 years was $52.7 million (2024), compared with a mean of $41.6 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 1264.84% in 2024 and later grew 10.1% in 2025.
  • Health In Tech's Shares Outstanding (Diluted Average) stood at $3.9 million in 2023, then skyrocketed by 1264.84% to $53.7 million in 2024, then rose by 6.21% to $57.0 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $57.0 million (Q1 2025), $53.7 million (Q4 2024), and $51.8 million (Q1 2024) per Business Quant data.